Sponsored by:

Nuclear Medicine: Page 372

Digirad, MarCap join in financing venture
By AuntMinnie.com staff writers
Nuclear medicine vendor Digirad and healthcare equipment financing firm MarCap of Chicago have signed an agreement to provide financing products for Digirad customers.
June 15, 2005
MDS Nordion brings Cu-64 to market
By AuntMinnie.com staff writers
Canadian radioisotope developer MDS Nordion of Kanata, Ontario, said that it has made the isotope copper-64 (Cu-64) commercially available.
June 15, 2005
Siemens forms new molecular imaging unit
By AuntMinnie.com staff writers
Siemens Medical Solutions of Malvern, PA, has formed a new molecular imaging division, to be called Siemens Medical Solutions Molecular Imaging.
June 12, 2005
Siemens and Gamma Medica part ways
By AuntMinnie.com staff writers
Nuclear medicine vendors Siemens Medical Solutions of Malvern, PA, and Gamma Medica of Northridge, CA, have allowed their co-marketing pact for preclinical SPECT and SPECT/CT products to expire.
May 30, 2005
Kirkpatrick named Research Corporation Technologies CEO
By AuntMinnie.com staff writers
Healthcare technology venture development firm Research Corporation Technologies (RCT) has selected Shaun Kirkpatrick as its president and chief executive officer.
May 25, 2005
MDS Nordion, Macrocyclics sign R&D accord
By AuntMinnie.com staff writers
Canadian radioisotope developer MDS Nordion and nuclear medicine and MRI ligand developer Macrocyclics have entered into a research and development collaboration to develop bifunctional chelates for use in molecular imaging and targeted therapeutic pharmaceuticals, the companies reported.
May 25, 2005
UltraSPECT gets CE Mark
By AuntMinnie.com staff writers
Nuclear medicine developer UltraSPECT of Haifa, Israel, has received the European CE Mark for its Wide Beam Reconstruction (WBR) product family.
May 23, 2005
Biotech firm Cell>Point sees promise for oncology SPECT
By Kate Madden Yee
Since its introduction in the 1990s, PET imaging has helped eclipse SPECT, which has long been used for oncology applications but lacks PET's image quality. Biotechnology company Cell>Point, however, hopes to capitalize on the large worldwide installed base of SPECT cameras by developing radiopharmaceuticals in new combinations. Their hope is to make oncology imaging as versatile and accurate on a SPECT system as it is on a PET camera.
May 19, 2005
2005 05 20 09 31 37 706
New Premier contract for Eastern Isotopes
By AuntMinnie.com staff writers
Isotope provider Eastern Isotopes has signed a new three-year contract to supply FDG to group purchasing organization Premier Purchasing Partners.
May 18, 2005
MDCT, scintigraphy yield very different reads on wrist fractures
By Tracie L. Thompson
Based on a head-to-head comparison with skeletal scintigraphy, British researchers have reluctantly concluded that MDCT probably shouldn't be the next step after initial x-rays fail to show a suspected wrist fracture.
May 17, 2005
2005 05 17 15 56 46 706
International Isotopes shows Q1 downturn
By AuntMinnie.com staff writers
Radioisotope manufacturer International Isotopes of Idaho Falls, ID, reported sales of $686,000, a 7.7% decrease compared with the $743,000 in revenue posted in the comparable quarter one year ago.
May 16, 2005
Draxis joins Nasdaq biotech index
By AuntMinnie.com staff writers
Canadian pharmaceutical developer Draxis Health said that its stock will be added to the Nasdaq Biotechnology Index.
May 15, 2005
Previous Page
Page 372 of 440
Next Page